Thanks to antiretroviral therapy and improved control of viral hepatitis (HBV and HCV), people living with HIV generally live longer and healthier lives. However, liver disease remains common in this population and is one ...
Aug 6, 2026
0
2
Hepatitis C remains a major cause of liver cirrhosis and liver cancer worldwide. Although highly effective antiviral medicines can cure most infections, many people remain undiagnosed or untreated because health care systems ...
Aug 5, 2026
0
2
Patients with inflammatory bowel disease (IBD) face a significantly higher risk of psychiatric disorders starting two to three years before diagnosis and lasting up to a decade afterward, according to a nationwide study published ...
Aug 5, 2026
0
9
The first results from the multicenter FUSOMAP project, published in ESMO Open and led by VHIO's Molecular Oncology Group, show that the presence of intratumoral Fusobacterium in surgical tumor samples identifies a clinically ...
Aug 4, 2026
0
3
Researchers have developed and evaluated a feedback initiative, returning gut microbiome results from a landmark microbiome study to 778 women in South Africa and Kenya. The results came from the AWI-Gen 2 study published ...
Aug 3, 2026
0
4
Two people have died in the cyclospora outbreak in Michigan in the first confirmed deaths in the U.S. related to the microscopic parasite, state health officials announced Monday.
Aug 3, 2026
0
3
Fermented plant-based foods such as kimchi and sauerkraut could help inspire a new generation of microbiome-informed dietary strategies for supporting oral and gut health, according to a review paper published in Nature Reviews ...
Aug 3, 2026
0
27
A Singapore team of clinician-scientists and researchers has developed a new tool that accurately predicts which liver cancer patients are likely to experience a recurrence after surgery. The machine-learning tool combines ...
Aug 3, 2026
0
8
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, offering a potential ...
Aug 1, 2026
0
8
For patients with metabolic dysfunction-associated steatotic liver disease (MASLD), the association between liver fibrosis and atherosclerotic cardiovascular disease (ASCVD) varies with glycemic status, according to a study ...
Jul 31, 2026
0
16
